August, 2003
No. 88 (8)



The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate (37 Online Views)

S Gatto, B Scappini, L Pham, F Onida, M Milella, G Ball, C Ricci, V Divoky, S Verstovsek, HM Kantarjian, MJ Keating, JE Cortes-Franco, M Beran

Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro (35 Online Views)

F Morabito, M Mangiola, D Rapezzi, S Zupo, BM Oliva, AM Ferraris, M Spriano, E Rossi, C Stelitano, V Callea, G Cutrona, M Ferrarini

Complexity of the genetic contribution to factor VII deficiency in two Spanish families: clinical and biological implications (93 Online Views)

M Sabater-Lleal, E Martinez-Marchan, E Martinez-Sanchez, M Coll, C Vallve, J Mateo, JC Souto, J Fontcuberta, JM Soria

Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation (199 Online Views)

MA Diaz, J Sevilla, J de la Rubia, A Verdeguer, I Espigado, MG Vicent, MJ Pascual, C Zamora, R Arrieta, D Serrano, C del Canizo, C Arbona, F de Arriba, J Bargay, S Brunet, MA Sanz

Letters to the Editor

Case Reports

Comparative Studies

Clinical Trial

Phase-II study of the new aza-anthracenedione, BBR 2778, in patients with relapsed aggressive non-Hodgkin's lymphomas (86 Online Views)

P Borchmann, F Morschhauser, A Parry, R Schnell, JL Harousseau, C Gisselbrecht, C Rudolph, M Wilhelm, H Gunther, DM Pfreundschuh, G Camboni, A Engert